Here's Why the Best Is Yet to Come for Opko Health Inc.
There's not a whole lot that looks good for Opko Health Inc. (NASDAQ: OPK) right now. The stock has dropped more than 30% so far in 2017. Several large institutional investors have reduced their positions in Opko. Although sales have risen, the company continues to lose a lot of money.
Some investors have given up entirely on Opko turning things around. However, I don't think you have to put on rose-colored glasses to see the potential long-term opportunity with the company. Here's why the best is yet to come for Opko Health.
Image source: Getty Images.
Source: Fool.com
Pfizer Inc. Stock
€25.78
-2.030%
With 31 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a hugely positive potential of 59.07% for Pfizer Inc. compared to the current price of 25.78 €.
